BriaCell Therapeutics Corp. (BCTX)
9.11
-0.43
(-4.51%)
USD |
NASDAQ |
Dec 15, 13:01
BriaCell Therapeutics EPS Diluted (Quarterly): -4.351 for Oct. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pharmagreen Biotech, Inc. | 0.0001 |
| Achieve Life Sciences, Inc. | -0.2831 |
| Oncolytics Biotech, Inc. | -0.1032 |
| Aurinia Pharmaceuticals, Inc. | 0.232 |
| Edesa Biotech, Inc. | -0.3157 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.278M |
| Total Expenses (Quarterly) | 8.198M |
| Enterprise Value | 5.940M |
| Earnings Yield | -530.8% |
| Normalized Earnings Yield | -559.27 |